We are live on
!
Find out more
RA
Rosalind Advisors Portfolio holdings
AUM
$244M
1-Year Est. Return
80.12%
This Fund
S&P 500
This Quarter
Est. Return
+42.01%
1 Year Est. Return
+80.12%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$283M
AUM Growth
+$76.3M
(+37%)
Cap. Flow
+$22.3M
Cap. Flow
% of AUM
7.89%
Top 10 Holdings %
Top 10 Hldgs %
62.15%
Holding
42
New
6
Increased
11
Reduced
7
Closed
6
Top Buys
| 1 |
ATXS
Astria Therapeutics
ATXS
|
+$10.4M |
| 2 |
EyePoint Inc
EYPT
|
+$7.48M |
| 3 |
Fractyl Health
GUTS
|
+$6.49M |
| 4 |
MediWound
MDWD
|
+$6.31M |
| 5 |
HELP
Cybin Inc
HELP
|
+$4.88M |
Top Sells
| 1 |
Ocular Therapeutix
OCUL
|
+$9.79M |
| 2 |
UroGen Pharma
URGN
|
+$7.43M |
| 3 |
Replimune Group
REPL
|
+$5.75M |
| 4 |
Pharvaris
PHVS
|
+$3.94M |
| 5 |
IDEAYA Biosciences
IDYA
|
+$3.9M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Delcath Systems
DCTH
$445M
| $33M | 11.66% |
3,300,389
| – | – |
|
2
Cytokinetics
CYTK
$10.9B
| $22M | 7.77% |
400,000
| – | – |
|
3
Fennec Pharmaceuticals
FENC
$389M
| $19.4M | 6.87% |
2,076,840
+31,196
| +2% | +$270K |
|
4
Verastem
VSTM
$476M
| $17M | 6.02% |
1,929,563
-114,000
| -6% | -$848K |
|
5
Rezolute
RZLT
$454M
| $17M | 6% |
1,807,202
+65,991
| +4% | +$439K |
|
6
Xeris Biopharma Holdings
XERS
$1.41B
| $14.6M | 5.17% |
1,795,766
-359,828
| -17% | -$2.39M |
|
7
Savara
SVRA
$1.15B
| $14.3M | 5.05% |
4,000,000
+1,345,056
| +51% | +$3.98M |
|
|
8
MediWound
MDWD
$186M
| $13.5M | 4.77% |
749,054
+341,993
| +84% | +$6.31M |
|
9
Viridian Therapeutics
VRDN
$2.08B
| $12.9M | 4.58% |
600,000
-100,000
| -14% | -$1.8M |
|
10
CG Oncology
CGON
$6.24B
| $12.1M | 4.27% |
300,000
+107,026
| +55% | +$3.11M |
|
|
VRNA
11
DELISTED
Verona Pharma
VRNA
| $10.7M | 3.77% |
100,000
| – | – |
|
|
12
IDEAYA Biosciences
IDYA
$3.49B
| $9.52M | 3.37% |
350,000
-161,132
| -32% | -$3.9M |
|
13
InspireMD
NSPR
$33.3M
| $9.41M | 3.33% |
3,905,743
+1,616,644
| +71% | +$3.92M |
|
|
14
EyePoint Inc
EYPT
$1.13B
| $9.26M | 3.27% |
+650,000
| New | +$7.48M |
|
|
DFTX
15
Definium Therapeutics
DFTX
$6.04B
| $8.84M | 3.12% |
750,000
+330,000
| +79% | +$3.08M |
|
|
HELP
16
Cybin Inc
HELP
$413M
| $8.84M | 3.12% |
1,500,000
+689,082
| +85% | +$4.88M |
|
|
17
Fractyl Health
GUTS
$131M
| $7.95M | 2.81% |
+5,000,000
| New | +$6.49M |
|
|
ATYR
18
aTyr Pharma
ATYR
$50.4M
| $7.56M | 2.67% |
+1,039,080
| New | +$4.71M |
|
19
uniQure
QURE
$2.8B
| $7.3M | 2.58% |
+125,000
| New | +$2.27M |
|
20
X4 Pharmaceuticals
XFOR
$375M
| $5.28M | 1.87% |
+1,544,607
| New | +$3.98M |
|
|
21
Ocular Therapeutix
OCUL
$2.08B
| $4.68M | 1.65% |
400,000
-818,700
| -67% | -$9.79M |
|
22
Talphera
TLPH
$72.7M
| $3.92M | 1.38% |
4,385,757
+2,381,818
| +119% | +$1.38M |
|
|
PROF
23
Profound Medical
PROF
$260M
| $3.38M | 1.2% |
692,185
| – | – |
|
24
Myomo
MYO
$44M
| $3.38M | 1.19% |
3,790,788
+195,000
| +5% | +$284K |
|
25
PolyPid
PYPD
$102M
| $3.06M | 1.08% |
918,668
-56,794
| -6% | -$197K |
|
Similar funds
AWG
BNMT
CA
BB
GIM
IAMOG
AWM
OCFG